The approval is supported by data from a phase 3 study that assessed the efficacy and safety of Botox in patients aged 5 to 17 years with urinary incontinence due to NDO and using clean intermittent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback